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Abstract
Background: According to the Center of Disease Control, stroke accounted for 1 in every 6
cardiovascular-related deaths in the U.S in 2018. This disease is the leading cause of long-term
disability and limits mobility in more than half of people who survive stroke older than 65
(Centers for Disease Control and Disease Prevention [CDC], 2020). Due to the difficulty of a full
recovery for cerebral vascular accidents, stroke prevention is the top priority in the approach to
reduce the mortality and morbidity of the disease. Antiplatelet platelet therapy has been proven
to reduce the incidence and complications of an ischemic stroke.
Context: A South Florida Hospital is less than excellent in initiating antiplatelet therapy for
patients suspected of ischemic stroke. An educational intervention should be provided to
healthcare providers to increase compliance to antiplatelet therapy for stroke patients.
Purpose: The objective of the quality improvement project is to improve healthcare providers’
knowledge and compliance towards initiating antiplatelet therapy for patients admitted to the
hospital with stroke symptoms.
Methods: A sample of 13 healthcare providers was provided with a link from the medical
director of an acute care hospital in South Florida via email. The link included the pre-test
survey, education intervention PowerPoint, and post-test survey. The pre-and post- test measure
of knowledge and practice habits related to treating patients with ischemic stroke.
Results: There was an 8.9% improvement in scores on the knowledge-based questions in the
post-test. Regarding the questions based on practice habits, post-test scores showed a 2%
increase when compared to similar pre-test questions.

Conclusions: Therefore, it was proven that the education intervention could improve the
knowledge of healthcare providers related to increasing compliance for prescribing antiplatelet
therapy for patients with stroke symptoms within 48 hours upon arrival to the hospital.

Keywords: CVA, cerebral vascular accident, stroke, adults, antiplatelet therapy,
provider adherence educational intervention
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Introduction
Problem Statement
Throughout the years, antiplatelet agents have been proven effective in reducing the
mortality, morbidity and recurrence of stroke. These medications help with patients with an acute
ischemic stroke or transient ischemic attack. In order for antiplatelet medications to be effective,
it is recommended that this medication is given to patients within 48 hours upon arrival to the
hospital as long as there are no contraindications. However, many healthcare providers are not
adhering to prescribing antiplatelets in a timely manner (“Cleveland Clinic Neurological
Institute,” n.d.).
Get With the Guidelines is a notable quality improvement program that evaluates
hospitals throughout the nation. This program provides statistics regarding effective treatments
for the American Stroke Association and American Heart Association. This encourages
healthcare providers to use current evidence-based guidelines to treat stroke patients by serving
as a reference. According to Get With the Guidelines, the national average for early antithrombic
initiation as at 97.5% in 2019 (“Cleveland Clinic Neurological Institute,” n.d.). The ultimate goal
is to be at 100%.
Background
A cerebral vascular accident, also known as stroke, occurs when there is an interruption
of blood flow to the brain. The brain is unable to receive oxygen and blood if the blood flow is
blocked for more than a few seconds. When this occurs, brain cells perish, which could result in
permanent damage. Ischemic and hemorrhage stroke are two main types of stroke. An ischemic
stroke happens when a blood clot blocks or clogs a vessel that supplies the brain with blood. On
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the other hand, a hemorrhagic stroke takes place when a blood vessel bursts open or there is a
blood leak into the brain (Sbampato dos Santos et al., 2017).
In most cases, a cerebral vascular accident is preventable by limiting the risk factors.
Atrial fibrillation, hypertension, heart disease, high cholesterol, and poor blood circulation are all
risk factors for stroke. Other risk factors include diabetes, family history of stroke, age older than
55, and unhealthy lifestyles (Sbampato dos Santos et al., 2017).
It is imperative to recognize the signs of stroke and act appropriately to reduce the effects of
the disease. Sudden one-sided numbness, weakness or paralysis in the face, arm or leg, confusion
is a common sign of stroke. Other signs of stroke include difficulty speaking, difficulty seeing,
difficulty walking, and dizziness (Sbampato dos Santos et al., 2017). A severe headache with an
unknown cause is also a sign of stroke, commonly hemorrhagic stroke. This may be associated
with facial pain or neck stiffness as well (Sbampato dos Santos et al., 2017).
Cerebral vascular accident is one of the world’s leading cause of mortality and disability.
Ischemic stroke and transient ischemic attack (TIA), are frequently followed by a recurrent
vascular event if not managed adequately. Ischemic stroke makes up 80-85% of all strokes
(Rothlisberger & Oybiagele, 2015). This type of stroke is commonly caused by large or small
blood clots in the artery or a blood clot that has traveled from the heart (Rothlisberger &
Oybiagele, 2015).
Furthermore, activated macrophages grow and constrict the artery by producing a
procoagulant tissue factor, which leads to the maturation of a thrombosis. Antiplatelet therapy is
used to prevent this from occurring. To limit the recurrence of stroke, patients should be on
antiplatelet if there are no contraindications. These antiplatelet medications include
acetylsalicyclic acid, clopidogrel, ticagrelor and several others (Rothlisberger & Oybiagele,
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2015). For patients being admitted to the hospital, it is recommended by Joint Commission to
initiate antiplatelet medications by the end of the second day of hospital admission. Antiplatelets
have shown to limit the mortality and recurrence rate of patients with ischemic stroke.
Antiplatelet therapy may be harmful for patients with a hemorrhagic stroke and could cause more
bleeding. Therefore, a CAT scan of the brain should be done to rule out hemorrhagic stroke prior
to initiating antiplatelet therapy (Rothlisberger & Oybiagele, 2015).
Scope of problem
Today, there is still a need for more effective treatment approaches towards stroke.
Cerebral vascular accident is still one of the world’s leading causes of long-term disability and
death. Stroke places a burden on patients, families, and society. In 2018, stroke accounted for 1
in every 6 cardiovascular-related deaths in the U.S. Cerebral vascular accidents is the leading
cause of long-term disability and limits mobility in more than half of people who survive stroke
older than 65. While someone experiences a stroke every 40 seconds, an individual dies from
stroke every 4 minutes (Centers for Disease Control and Disease Prevention [CDC], 2020).
Cerebral vascular accidents affect about 800,000 people every year; with about 600,000
experiencing strokes for the first time. Ischemic strokes are responsible for 87% of all strokes
(CDC, 2020). Between 2014-2015, Cerebral vascular accidents have cost the United States about
$46 billion, which includes medications and health care services to treat the disease and missed
workdays (CDC, 2020).
The effects of stroke varies in different ethnic groups. The risk of experiencing a stroke
for the first time is almost twice as high for African American compared to whites (CDC, 2020).
Stroke causes the highest death rate for blacks. Although stroke-related deaths have decline in
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many ethnic groups, Hispanics has seen an increase in death rates. Stroke affects individuals of
all ages. In 2009, 34% of people less than 65 years old were hospitalized for stroke (CDC, 2020).
Locally, stroke is the third leading cause of death in Miami‐Dade County. This condition
accounts for 41.5 deaths per 100,000 population from 2015-2017. Stroke continues to be a
significant cause of disability and a significant contributor to increases in healthcare costs in the
United States (Florida Department of Health in Miami-Dade County, 2019).
In 2010, the mortality and morbidity of stroke impacted the United States by $73 billion
(Rothlisberger & Oybiagele, 2015). Due to the difficulty of a full recovery for cerebral vascular
accidents, stroke prevention is the top priority in the approach to reduce the mortality and
morbidity of the disease. Stroke prevention is also vital for patients who have already had a
stroke or transient ischemic attack to limit the recurrency rates (Rothlisberger & Oybiagele,
2015).
Stroke also has a worldwide effect. It is the second leading cause of death and it’s
significant cause of disability globally. As the population ages, the incidence of stroke also
increases. And low and middle-income countries, more young people (20-64 years of age) are
affected by stroke (Katan & Luft, 2018). This is seen in certain regions in Russia, China, and
India. For example, about 12% of stroke in India occur in individuals younger than 40 years old
(Katan & Luft, 2018). In high income nations, improvements have been seen in stroke
prevention, acute treatment, and rehabilitation, which has led to a significant decrease in the
burden of stroke over the past 30 years. Cerebral vascular accident are largely preventable due
to modifiable risk factors. These risk factors include hypertension, obesity, smoking, diabetes,
dyslipidemia, atrial fibrillation, and lack of exercise. High income countries have an advantage
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of addressing these modifiable risk factors; therefore, there has been a decrease in the burden of
stroke compared to low and middle income countries (Katan & Luft, 2018).
In 2010, the total annual direct costs were estimated at €26.6 billion for the European
Union, Iceland, Norway, and Switzerland (Katan & Luft, 2018). It is believed that India lost
about $54 billion in 2015 due to coronary heart disease, stroke, and diabetes (Katan & Luft,
2018). From 2005-2015, China is believe the laws a national income of about $558 billion due to
coronavirus disease, stroke, and diabetes (Katan & Luft, 2018).
The health disparities of stroke are universal at widespread. Is affected by the ability to
afford necessary medical infrastructure and personnel, imbalance access to healthcare, low health
literacy, and issues with adherence and compliance and the primary and secondary prevention of
stroke care. In terms of gender, the world health organization reported more stroke related deaths
among women compared to men between 1990 and 2006, of which 60% accurate in those aged
over 75 years of age (Katan & Luft, 2018).
Consequences of the problem
Cerebral vascular accidents impact an individual physically, economically, and mentally.
Due to the various functions of the brain, a lack of blood flow to a region that controls a
particular body function can cause the body part not to work. For example, a stroke that occurs in
the occipital region of the brain can cause visual issues. The effect of the cerebral vascular
accident is dependent on the location of the blood flow blockage and how much tissue of the
brain is affected (CDC, 2020).
Physical Consequences. Due to the fact that one side of the brain regulates the opposite
side of the body, a stroke on one side could affect the other side of the body. For example, a
stroke of the left brain can result in right sided paralysis, weakness, numbness, and speech
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abnormalities. A right sided stroke can lead to left sided paralysis, weakness, numbness, and
visual issues. Visual issues include but are not limited to visual field loss, abnormal eye
movement, visual processing issues, and light sensitivity. A stroke at the brain stem can affect
both sides leaving individuals in a locked state, where someone can find difficulty speaking or
achieving any movements below the neck (CDC, 2020). Stroke can also affect someone’s sense
of smell and taste. Individuals who have had a stroke have also reported difficulty swallowing.
Bladder and bowel incontinence have also been seen in stroke victims. Therefore, a stroke could
have a profound effect on someone’s quality of life. Stroke survivors also find difficulty
performing daily activities that requires multiple limbs, such as eating, dressing, walking,
cleaning around the house, toileting, and driving (Lo Buono, Corallo, Bramanti, & Marino,
2017).
Financial Consequences. Beside the physical consequences of stroke, there are also
financial impacts. An ischemic stroke costs the United States about $50 billion a year (Majersik
& Woo, 2020). This cost represents acute care hospitalization, initial rehabilitation, follow up
visits, medications, and income loss from missing workdays (Majersik & Woo, 2020). Stroke
patients are admitted to specialized units, such as stroke, intermediate care or intensive care
units. Stroke patients should also be evaluated by a neurologist, physical therapist, occupational
therapist, and speech therapist. Majority of stroke patients must undergo a brain MRI. Patients
with residual defects of the stroke are often recommended rehabilitation therapy, which can last
several weeks or more. All of these requirements during hospitalization contribute to a costly
hospital admission. After hospitalization, patients are recommended to follow appointments with
their primary care providers and neurologist. Follow up appointments are necessary to prevent
recurrent stroke. This can lead to higher healthcare spending. Medication, such as anti-platelets,
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anticoagulants, cholesterol, are often suggested for stroke victims. Medications can be costly as
well. One sided weakness could limit an individual from working a job that requires physical
labor. This can result in job loss or decrease in pay as one may not be able to contribute to the
occupation similarly to the way one did before the stroke.
Emotional/Behavioral Consequences. A cerebral vascular accident could also lead to
emotional and behavioral changes. Depending on the area affected by the stroke, biochemical
changes may occur. These victims could experience confusion, carelessness, irritability,
forgetfulness, depression, anxiety, and anger (Lo Buono, Corallo, Bramanti, & Marino, 2017).
Neglect is often seen in stroke victims. Neglect occurs when a victim does not pay attention to
things on one side of the body. They may also ignore food that is on the affected side of the
body. Apathy is also seen in stroke victims. This occurs when survivors lose interest in an
activity. Stroke survivors may also experience grief as they face lifestyle modifications to cope
with their disabilities. Also, stroke may affect an individual’s sex drive as well. No behavioral
changes can overwhelm the victims caretaker or a loved one as well. Therefore, there is a
significant emotional impact on stroke survivors (Lo Buono, Corallo, Bramanti, & Marino,
2017).
Knowledge Gaps
There are several knowledge gaps that can affect early initiation of antiplatelet therapy
amongst healthcare providers in treating patients with ischemic stroke. Many clinicians find it
difficult to detect patients with ischemic stroke. Healthcare providers tend to wait until the MRI
is done to determine whether or not to initiate antiplatelet therapy (Lambda et al. 2013). MRIs
are further delayed due to lack of staff. Many hospitals do not have MRI technicians working at
night; therefore, the MRI technicians may be delayed until the morning or the next day. This can
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cause the delay to extend beyond the 48-hour period. Clinicians must understand to initiate
antiplatelet therapy for patients with suspected stroke as soon as possible if there are no
contraindications (Igbal et al., 2020).
Healthcare providers may also feel uncomfortable to begin antiplatelet therapy due to
certain contraindications. Therefore, healthcare providers must educate themselves on the
contraindications of antiplatelet therapy. Antiplatelet therapy should be used with caution when
prescribed to patients with certain conditions such as antiplatelet-induced dyspnea, nasal polyps,
gastrointestinal bleeding, hematuria, epistaxis, hemorrhage, and low platelets (Igbal et al., 2020).
Most common contraindications of antiplatelet therapy include large esophageal varices,
intracranial hemorrhage, significant thrombocytopenia, major surgery within 72 hours,
hypersensitivity to medication, acute significant bleeding, severe hypertension with a blood
pressure above 200/110 mmHg (Igbal et al., 2020). In these scenarios, it is recommended to
consult with a neurologist to determine the need for antiplatelet therapy. Other barriers to initiate
antiplatelet therapy includes discussing treatment with patients. Many patients are be reluctant to
start antiplatelet therapy due to higher risk of bleeding. They may not understand that the
benefits outweigh the risk. Therefore, it requires knowledge from the clinician to be able to
explain the significance of antiplatelet therapy. Poor communication among healthcare providers
and specialists may also lead to delays in antiplatelet therapy initiation (Igbal et al., 2020).
Proposal solution
As previously discussed, it is apparent that knowledge gaps can delay the initiation of
antiplatelet therapy. To address this knowledge gaps, an educational intervention can be done to
help bridge the knowledge gaps. Educational intervention has been proven effective in educating
healthcare providers (Akwe & Wallace, 2018). Clinicians would be more encouraged to initiate
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antiplatelet therapy without waiting for the MRI to be done. Also, they would also be more
comfortable prescribe antiplatelets and more cautious when dealing with patients with certain
contraindications. When making tough decisions, healthcare providers are encouraged to consult
with the neurologist. This quality improvement project includes a pre-test and post-test design to
evaluate effectiveness of the educational intervention (Akwe & Wallace, 2018).
Summary of the Literature
Stroke is the nation’s leading cause of long-term disability. It affects many Americans
today. Due to the difficulty of having a full recovery from a cerebrovascular accident, stroke
prevention is the priority in treating stroke patients (Akwe & Wallace, 2018). An educational
intervention could be used to encourage healthcare providers to initiate antiplatelet therapy for
patients with stroke symptoms within 48 hours upon arrival to the hospital. The PICO question
for this proposed study is as follows: Healthcare providers at an acute care hospital in South
Florida (P) who have received an educational intervention (I) gain more knowledge than before
how they were before receiving an educational intervention (C) in initiating antiplatelet therapy
within 48 hours upon arrival to hospital (O). This paper presents a literature review on this topic.
Expanding on the PICO question, subject terms and keywords were found and used in
several database searches. When performing the review, a search strategy was in place.
CINAHL, Embase, Ebcohost, and PUBMED were the search engines used during this review.
Keywords, such as “antiplatelet”, “CVA”, “cerebral vascular accidents”, “stroke”, “TIA”,
“transient ischemic attack”, “stroke core measures”, “adherence”, “compliance” and “quality
improvement” were used. The search was limited to results between 2015-2020, and articles
published in the English language.
Utilizing Order Sets

10
In this study, electronic health records were created to increase compliance to Joint
Commission National Quality Measures for treating veterans with ischemic stroke. The sample
took place at the Atlanta Veteran Medical Center. These patients were admitted for a stroke work
up to the internal medicine service. This service included an admitting physician, an internal
medicine resident, a pharmacist, a nurse practitioner, and two interns. From the 93 patients
admitted using the stroke order set, 80% veterans received antiplatelet therapy by the end of
hospital day 2 compared to 73 % veterans who were admitted without using the stroke order sets
(Akwe & Wallace, 2018). Order sets are evidence-based admission orders that guides clinicians
on the treatment of stroke patients. These order sets included early antiplatelet initiation and
several other core measures developed by the Joint Commission. Healthcare providers were
educated on the significance of these order sets and how to use them. The study suggested that
orders sets help close the gap in meeting this core measure based on the results of the study. This
research proved that using order sets improved the adherence of health care personnel in
administering antiplatelets before the end of day 2 for ischemic stroke patients. The research
article is relevant to my clinical question as it provides insight on methods to improve adherence
to timely antiplatelet therapy initiation (Akwe & Wallace, 2018).
Concurrent Reviews
Many hospitals have used quality improvement strategies, such as concurrent reviews, to
improve compliance to stroke core measures, such as early antiplatelet initiation. Gomes and
Silver (2017) analyzed two different hospitals using concurrent review. Concurrent review is a
quality improvement method that involves a daily analysis of patients admitted with stroke
diagnosis and an evaluation to determine if the healthcare provider’s care plan complied with the
latest standard of care for stroke management. (Gomes McGillivray & Silver, 2017). For missing
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items, the stroke coordinator provided an educational intervention by using direct feedback to the
clinician within a day. Charts were randomly selected from two hospitals (A and B) during 3
different time periods. In period 1, none of the hospitals had a process for concurrent reviews. In
period 2, hospital A, underwent concurrent reviews and was compared with hospital B without
concurrent reviews. In period 3, both hospitals had the process of concurrent reviews. Despite
the fact that hospital B had a higher number of beds and annual stroke volume, patient
characteristics were similar. During period 2, hospital A applied concurrent reviews and hospital
B did not. In Hospital A, 90% patients with stroke symptoms were prescribed antiplatelets within
48 hours upon arrival to the hospital compared to 86% in hospital B who did not implement the
concurrent reviews. Both hospitals utilized concurrent review in period 3. Hospital A improved
from 60% to 100%; while Hospital B improved from 77% to 93% in period 3. This study had
several limitations. One limitation was the possible effect of external influences. The Joint
Commission promoted stroke education to increase quality care and focused on specific core
measures, such as early antiplatelet initiation. The study concluded that concurrent review is an
effective quality improvement method to increase compliance to stroke measures, such as early
antiplatelet initiation; hence, making this study relevant (Gomes McGillivray & Silver, 2017).

Multifaceted Quality Improvement Projects

A total of eight studies were reviewed as researchers explored the impact of an
educational intervention developed to increase healthcare provider’s adherence to initiating
antiplatelet therapy for patients with stroke symptoms within 48 hours upon arrival to the
hospital. While three of the studies involved over 2000 study subjects, the others involved from
302-1700 study subjects. The intervention in these studies involved implementing a multifaceted
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quality improvement project, such as improving the electronic medical records, providing
educational materials, interactive workshops and providing feedback reports (Machline-Carrion
et al., 2019). The results proved that these quality improvement interventions did improve the
clinician’s adherence to initiating early antiplatelet therapy for patients with stroke symptoms.
In their study, Machline-Carrion et al. (2019) utilized a multifaceted quality improvement
method to increase adherence to initiating early antiplatelet therapy. They used a method called
BRIDGE stroke multifaceted quality improvement intervention. This strategy included
reminders, healthcare providers educational materials, case management, treatment algorithm,
audit and feedback reports, and interactive workshop (Machline-Carrion et al., 2019). The
researchers used a pragmatic, two arm clustered randomized trial that involve 36 clusters and
1624 patients from Brazil, Argentina, and Peru. This method gave the strongest level of
evidence, level 1. This made their study have a good validity and high reliability. Therefore, this
research design made the findings credible (Machline-Carrion et al., 2019).
A similar study was conducted by Wang et al. (2018). The researchers aimed to
determine whether a multi-faceted quality improvement intervention could improve healthcare
personnel adherence to evidence-based performance measures in patients with stroke symptoms
in China. They conducted a cluster randomized clinical trial that included 4800 patients from 40
different hospitals from August 10, 2014, through June 20, 2015, with a 12-month follow up
through July 30, 2016 (Wang et al., 2018). Half of the hospitals received the multifaceted quality
improvement intervention; while the other half did not. The multifaceted quality improvement
intervention included educational intervention, care protocols, clinical pathways, quality
coordinator oversight, and feedback report. The study revealed a 4.2% increase from the
intervention group and a control group in adherence to early antiplatelet therapy initiation (Wang
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et al., 2018). Therefore, the multifaceted quality improvement intervention was proven effective
in increasing adherence from healthcare personnel and initiating early antiplatelet therapy.
Patients who present to the emergency department with symptoms, such as syncope,
altered mental status, and other non-localized complaints, can also be diagnosed with a stroke.
This type of patients is known as a stroke chameleon. Healthcare providers must recognize these
symptoms because they are more likely to not to receive antiplatelet therapy in a timely fashion.
Gribko et al. (2017) conducted a performance improvement project to improve stroke core
measure compliance by performing educational intervention that educated clinicians on how to
assess patients not admitted in a stroke unit. The study revealed an increase from 84% to 85.3%
in early platelet initiation (Gribko et al, 2017). This study is relevant because it targets the
patients that are often missed by clinicians in order for them to provide patients with the
appropriate treatment, such as early antiplatelet initiation.
In another study, Su et al. (2017) aimed to analyze the effects of utilizing an educational
intervention that promoted antiplatelet prescribing for patients with ischemic stroke. This study
took place in Hainan province, China. The interventional group of study included five hospitals,
who participated in the educational intervention. This study included 613 stroke patients. The
control group included the usual stroke management program. After a year, the amount of
patients prescribed on antiplatelets increased substantially, “reaching 73.2%, with a pre-post
difference between two arms of 22.9% ( P < 0.01) (Su et al, 2017). Therefore, the health
promotion program was successful in increasing the healthcare provider’s adherence to
antiplatelet therapy (Su, 2017).
In a separate study in efforts to address knowledge gaps with thrombolytics in stroke
therapy, Lamba, Murano, Nagurka (2013) examined basic stroke management concepts and
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ischemic stroke therapy in healthcare providers working in the Emergency Department and then
assessed the impact of the educational intervention. These researchers used a 14-item
questionnaire, which included 11 multiple choice and 3 open ended questions; this was given to
58 healthcare providers in a Level 1, academic, urban hospital. A 15-minute lecture was
provided and a post-test was administered immediately and 6 months after. Out of the 58
participants, 77% recognized r-TPA as a thrombolytic agent, 62% reported unfamiliarity with the
National Institute of Health’s Stroke Scale and the eligibility criteria, 56% identified the
therapeutic window, and 29% knew the “Door-to-CT” time (Lamba, Murano, & Nagurka, 2013).
The educational intervention resulted in an increase in median score from 5/14 pre-education to
11/14 post educational intervention (Lamba, Murano, & Nagurka, 2013). This study is effective
in improving knowledge of stroke guidelines and may subsequently improve prescribing
behaviors.
Gutierrez-Jimenez et al. (2011) also examined the impact of an educational program by
targeting medical students. During this study, researchers gave individuals a survey to determine
the knowledge of the warning signs and risk factors of ischemic stroke. The participants then
underwent six month education program, which was then followed by a post-educational
intervention survey. Researchers noticed an increase from 57.1% to 65.9% in participants that
were able to recognize risk factors (Gutiérrez-Jiménez et al., 2011). In regard to warning signs of
stroke, the educational intervention improved from 37.6% to 48.1% for participants being able to
recognize signs of stroke (Gutiérrez-Jiménez et al., 2011). This relevant study shows that
educating novice healthcare providers helps them recognize warning signs and risk factors of
stroke in order to prevent delay of care.
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Ma et al. (2017) also aimed to assess the knowledge of physicians regarding fibrinolytic
therapy for acute ischemic stroke in efforts to improve utilization fibrinolytic therapy in China.
Physicians completed a 12 multiple-choice question on the basic knowledge of intravenous
fibrinolytic therapy for acute ischemic stroke. These questionnaire assessed: time window for
fibrinolysis, imaging results required fibrinolysis, lab results required for fibrinolysis, dose of
alteplase, and several scenarios on whether or not to administer fibrinolytic therapy. Results
showed that the mean accuracy rate of 12 questions was 54.9 ± 25.01% (range 0.8–96.2%) (Ma
et al., 2017). This represents a knowledge deficit among healthcare providers, which can be
address with an educational intervention.
From this literature review, it was proven that there are effective quality improvement
interventions towards increasing clinicians’ adherence to initiating early antiplatelet therapy for
patients with stroke symptoms. The quality improvement method focused on an educational
intervention that addressed proper utilization of updating orders sets, using concurrent reviews to
educate staff, and promoting educational workshops in efforts to increase the knowledge of
clinicians. Increasing the knowledge of healthcare provider’s will help bridge the knowledge gap
and increase compliance to early antiplatelet therapy initiation. Overall, this literature review
supports my quality improvement project by addressing different types of educational
intervention.
Author
Akwe & Wallace, 2018

Method
The hospitalist at Alana
veterinary Medical Center
conducted a study that
involved where clinicians
were educated on using
evidence-based admission
orders for all patients
admitted for stroke or
TIA. Results were

Summary of Findings
From the 93 patients admitted
using the stroke order set, 80%
veterans received antiplatelet
therapy by the end of hospital
day 2 compared to 73 %
veterans who were admitted
without using the stroke order
sets.
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Gomes & Silver, 2018

620 charts from 2
hospitals (A and B) were
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3 time periods were
reviewed. In period 1,
none of the hospital had a
process for concurrent
review. In period 2,
hospital A, where
concurrent review was
implemented, was
compared with In period
2, hospital A, where
concurrent review was
done, was compared with
hospital B, without the
concurrent reviews. In
period 3, both hospitals
received the process.

During period 2, hospital A
applied concurrent reviews and
hospital B did not. In Hospital
A, 90% patients with stroke
symptoms were prescribed
antiplatelets within 48 hours
upon arrival to the hospital
compared to 86% in hospital B
who did not implement the
concurrent reviews. Both
hospitals utilized concurrent
review in period 3. Hospital A
improved from 60% to 100%;
while Hospital B improved from
77% to 93% in period 3.
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Researchers utilized a
randomized controlled
trial that involved 36
clusters and 1624 patients
from Brazil, Argentina,
and Peru. They conducted
a multifaceted quality
improvement method,
named BRIDGE stroke
multifaceted quality
improvement intervention,
to increase adherence to
initiating early antiplatelet
therapy.
They conducted a cluster
randomized clinical trial
that included 4800
patients from 40 different
hospitals from August 10,
2014, through June 20,
2015, with a 12-month

The quality improvement project
access at the bridge ACS Trail
resulted in an 18% increase of
uptake of evidence-based
therapies during the first 24
hours, as seen but increased
prescription rates of antithrombotic therapies and statins.

Wang et al., 2018

The study revealed a 4.2%
increase from the intervention
group and a control group in
adherence to early antiplatelet
therapy initiation.
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Gribko et al., 2017

Su et al., 2017

Lamba, Murano, Nagurka,
2013

Gutierrez-Jimenez et al.,
2011

follow up through July 30,
2016 (Wang et al., 2018).
Half of the hospitals
received the multifaceted
quality improvement
intervention; while the
other half did not.
Researchers conducted a
The study revealed an increase
performance initiative that from 84% to 85.3% in early
included educating
platelet initiation.
clinicians and using a
stroke core measure
checklist. Compliance was
measured 24 months preintervention and 12
months post intervention.
This was a three-year
study that took place in a
comprehensive stroke
center and included 3,355
patients who had a stroke
diagnosis.
The researchers utilize a
pre- and post-educational
intervention program that
involve 613 stroke
patients to promote antiplatelet prescribing for a
patient with ischemic
stroke.
The researchers aimed to
improve stroke therapy in
healthcare providers
working in the Emergency
Department. They used a
pre and post-test
educational intervention
that included a 15 minute
lecture followed by an
immediate posttest and a
posttest that followed 6
months after. There were
58 participants.
Researchers conducted a
pre- and post-educational

After a year, the amount of
patients prescribed on
antiplatelets increased
substantially, reaching 73.2%,
with a pre-post difference
between two arms of 22.9%.

The educational intervention
resulted in an increase in median
score from 5/14 pre-education to
11/14 post educational
intervention.

Researchers noticed an increase
from 57.1% to 65.9% in
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Ma et al., 2017

intervention that assessed
the knowledge of fourth
year medical students in
regard to warning signs
and risk factors of stroke.
Medical students were
from the School of
Medicine of the
Universidad Autonoma de
Nuevo Leon in Monterrey,
Mexico.
Researchers perform 329
pre-test and 355 posttest
surveys.

participants that were able to
recognize risk factors
(Gutiérrez-Jiménez et al., 2011).
In regard to warning signs of
stroke, the educational
intervention improved from
37.6% to 48.1% for participants
being able to recognize signs of
stroke.

Authors aimed to assess
the knowledge of
physicians regarding
fibrinolytic therapy for
acute ischemic stroke in
efforts to improve
utilization fibrinolytic
therapy in China.
Physicians completed a 12
multiple-choice question

Results showed that the mean
accuracy rate of 12 questions
was 54.9 ± 25.01% (range 0.8–
96.2%)

Purpose/PICO Clinical Questions/Objectives
Will an educational intervention improve healthcare providers’ adherence to prescribe
antiplatelet therapy to stroke patients within the recommended timeframe.
Population: Healthcare provider’s at an acute care in South Florida
Intervention: Performing an educational intervention to improve healthcare providers’
adherence to prescribe antiplatelet therapy within the first 48 hours upon arrival for
patients with stroke symptoms
Comparison: Pre-Post Test
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Outcome: Improved adherence to prescribing antiplatelet therapy within the first 48
hours upon arrival for patients with stroke symptoms Knowledge should be here.
Specific: To increase the adherence of healthcare providers initiating antiplatelet therapy
for patients with stroke symptoms within 48 hours upon arrival to an acute care hospital in South
Florida.
Measurable: Compare the adherence rate of healthcare providers prescribing
antiplatelets for patients with stroke symptoms within 48 hours upon arrival with the adherence
rate for healthcare providers prescribing antiplatelets for stroke patients within 48 hours after the
educational intervention. For immediate results, a pre-test and post-test would be given to
providers after an educational intervention.
Attainable/Achievable: To perform a quasi experimental pre and post test design to
analyze the effects of implementating of educational interventions to improve adherence for
healthcare providers initiating antiplatelet therapy within the first 48 hours upon arrival to the
hospital in a three-month time span.
Relevant: Today, more effective treatment towards stroke is needed. Stroke is one of the
nation’s leading cause of long-term disability. This disease puts a burden on patients, their
families, and society. There are physical, mental and financial impacts of cerebrovascular
accidents. From a physical standpoint, a stroke in one side of the brain can result in symptoms on
the other side of the body. These symptoms include one-sided paralysis, weakness, numbness,
and speech abnormalities. Stroke symptoms could prevent an individual from carrying out work
duties. Victims of stroke have a hard time doing daily functions, such as dressing, eating,
driving, toileting, and cleaning around the house (Lo Buono, Corallo, Bramanti, & Marino,
2017). Ischemic stroke has cost society nearly $50 billion a year in acute care hospitalization,
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follow up visits, medications, initial rehabilitation, and income loss from missing workdays
(Majersik & Woo, 2020). Mentally, biochemical changes in the brain can occur due to stroke.
These changes could lead to carelessness, confusion, forgetfulness, irritability, anxiety, and
depression in stroke victims (Lo Buono, Corallo, Bramanti, & Marino, 2017). Many stroke
victims must learn to cope with their disabilities, which may cause grief. It is also known that
stroke may affect one’s libido as well. Thus, stroke has a substantial impact on its victims (Lo
Buono, Corallo, Bramanti, & Marino, 2017).
It is very difficult to expect a full recovery from stroke; hence, the top priority of treating
cerebral vascular accidents is to prevent it with several measures, such as early initiation of
antiplatelet therapy. Stroke prevention is also important for victims who already had a stroke or
transient ischemic attack as recurrent strokes can be limited (Rothlisberger & Oybiagele, 2015).
As previously stated, stroke is responsible for 41.5 deaths per 100,000 population in Miami-Dade
alone (Florida Department of Health in Miami-Dade County, 2019). Currently at this chosen
acute care hospital in South Florida, 91% of patients have received antiplatelet therapy within the
first 48 hours upon arrival within March to July (“Aventura Hospital,” n.d.). The goal is to
increase that percentage to 100%. Improving early initiation of antiplatelet therapy by nine
percent can have a significant impact on society, patients and their loved ones.
Time: Over a span of 3 months
Definition of Terms
Antiplatelet- medication that prevents cells in the blood from sticking together and creating a
clot
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Tissue plasminogen activator (TPA)- serine protease enzyme that dissolves blood clots by
serving as a catalyst to convert plasminogen to plasmin, main enzyme involved in dissolving
blood clots.
Cerebrovascular accident- when blood flow to an area of the brain is interrupted by a blockage
or rupture in the blood vessel.
Hemorrhagic stroke- type of stroke that occurs when a weakened blood vessel in the brain
breaks and bleeding occurs
Ischemic stroke- type of stroke that takes place when there is a blockage in a blood vessel in the
brain
Order Sets- a group of orders that a clinician uses to direct other healthcare workers regarding
the treatment of a patient
Stroke symptoms- sudden difficulty speaking, walking, understanding, and one-sided
weakness/numbness in the face, arm or leg.
Transient ischemic attack (TIA)- takes place a blood flow to the brain is interrupted for s short
amount of time, often less than 15 minutes
Methodology
The Plan-Do-Study-Act (PDSA) methodology model will be used as a reference to guide
the quality improvement project (Spath & Kelly, 2017). The PDSA method is a highly
respectable tool for developing, implementing, and reviewing a quality improvement project on a
smaller platform before executing the project on a larger platform. This method is frequently
used for quality improvement in many institutions (Spath & Kelly, 2017). The Plan part of the
PDSA method involves doing a literature review. A literature review was conducted to review
systematic reviews, meta-analysis, and primary research studies. It is vital to have relevant
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sources that are connected to my clinical question: Can an educational intervention increase
healthcare providers adherence to early antiplatelet therapy initiation for stroke patients within
48 hours upon arrival to the hospital? In conducting the literature review, a sufficient amount of
evidence was found to back my clinical question. The literature review contained quality
improvement methods, which included a pre-test and post-test survey that assessed the
effectiveness of an educational intervention. The Do aspect of the PDSA method involves the
educational intervention. Healthcare providers will be taught the benefits of early antiplatelet
therapy initiation in efforts to increase compliance. The study portion of the PDSA method
encompasses utilizing an independent t-test to analyze the difference between the pre-test and
post-test. This would measure the effectiveness of the educational intervention. Act is the last
step of the PDSA method, which involves carrying out the action. If the educational intervention
has been proven effective in increasing healthcare provider’s compliance to initiating early
antiplatelet therapy, more participants can be used for educational intervention to improve
quality in stroke care. If the educational intervention produces minimal or negative results, a
reevaluation of efforts and measures will take place (Moran, 2020).
Settings and Participants
In Miami-Dade County, cerebral vascular accidents are the third leading cause of death.
Stroke has been responsible for 41.5 deaths per 100,000 population from 2015-2017 (Florida
Department of Health in Miami-Dade County, 2019). This condition leads to an increase
disability and healthcare costs in the community (Florida Department of Health in Miami-Dade
County, 2019). Therefore, it is essential to prevent stroke or minimize the effects of stroke,
especially recurrent stroke. Antiplatelet therapy has been proven to significantly prevent or
minimize the effects of stroke (Johnston et al., 2018).

23
The chosen acute care hospital in South Florida is a private hospital in Miami-Dade
County that holds over 400 beds. This hospital also has a stroke team that includes many
specialties, such as neurology, neurosurgery, neuro-interventionists, and neuroradiologist. The
DNP student will be working with the stroke committee leader, Dr. Lozen, in performing an
educational intervention to increase compliance to early initiation of antiplatelet therapy. In this
hospital, 91% of patients have been started on antiplatelet therapy within the first 48 hours upon
arrival within March to July (“Aventura Hospital,” n.d.). The goal is to have 100% of eligible
patients suspected for ischemic stroke to be initiated on antiplatelet therapy. The participants of
this project include internal medicine and neurology healthcare providers. This includes
physicians, internal medicine residents, nurse practitioners, and physician assistants. This makes
up about 25 healthcare providers. The inclusion criteria for healthcare providers included fulltime physicians, internal medicine residents, medical fellows, nurse practitioners, and physician
assistants. These participants are all over the age of 21 and can speak, write, and read English.
They are all eligible to initiate antiplatelet therapy. Per diem employees were excluded from the
sample (Moran et al, 2020).
Design
This quality improvement project was designed as a quasi-experimental pre-test/post-test
intervention. It is pending review and approval for use with human subjects and deemed exempt
by Florida International University’s Internal Review Board. The project consisted of three main
components. The first part was an initial assessment of providers' knowledge and practices
regarding ischemic stroke treatment guidelines. After the pre-test, an educational intervention
was delivered by a PowerPoint presentation. Following the presentation, there would be time for

24
questions and then a post-test would be completed to assess the effects of the educational
intervention (Moran et al., 2020).
The pre-test consisted of an electronic questionnaire developed by the DNP student using
the Qualtrics system. It included two demographic questions, 11 self-assessment questions of
knowledge of ischemic stroke, and six questions that assess habits. The pre-test and post-tests
and the intervention were developed by the DNP student and were reviewed for validity by an
expert physician specialized in neurology (Moran et al, 2020).
A literature review was used in the development of the PowerPoint educational
intervention. The PowerPoint presentation provides a comfortable atmosphere for healthcare
providers that will participate in this quality improvement project (Moran et al, 2020). The
educational intervention considers the skill levels, attitudes, and prior knowledge of the
healthcare providers. This educational intervention is also relevant to their practice as these
participants either work in internal medicine or neurology, where many stroke patients are
encountered. The educational intervention would last no longer than an hour to take the
participant’s personal/work time into consideration. Time for questions and feedback related to
the intervention was also recognized as an essential component. The success of the educational
intervention can lead to organizational benefits as better policy may be created to promote more
compliance for early antiplatelet initiation (Moran et al, 2020).
In developing the educational intervention, relevant topics were discussed that affected
the practice of healthcare providers. For example, they were taught about proper dosing, location
of stroke order sets, and practice habits that affect timely initiation of antiplatelet therapy. The
hospital environment was taken under consideration when developing the educational
intervention (Moran et al, 2020). The quality improvement project focuses on the scope of the
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problem of ischemic stroke and treatment, specifically antiplatelet therapy using evidence-based
guidelines of the NIHSS. This would be delivered through Zoom, which allows participants to
ask questions verbally and via chatbox (Moran et al, 2020).
Procedures and Measures
With the assistance of the medical director of the acute care hospital’s stroke committee,
Dr. Andrew Lozen, the DNP student developed a virtual educational intervention, which
included a pre-test to each participant’s email through an anonymous link for the Qualtrics
system.
Due to the restrictions of COVID-19, large gatherings are not allowed from the Governor
of Florida. No names or identifiers were included in the survey to protect privacy. Following a
short introduction by the DNP student, the participants will be asked to sign an informational
consent and take a pre-test. After the pre-test, an educational intervention will be delivered
through a PowerPoint presentation. A post-test followed the educational intervention to measure
the effectiveness of the presentation. The educational intervention should not last longer than 60
minutes. The pre-test and post-test should last about 10 minutes (Moran et al, 2020).
During the presentation, any questions that are verbally asked or submitted through the
chatbox of the Zoom platform will be addressed by the DNP student. After the PowerPoint
presentation, the link for the post-test was provided through an anonymous link to the Qualtrics
system through the email or Zoom chat box. The post-test concluded the presentation (Moran et
al, 2020).
Recruitment
An email would be used to announce to reach out to healthcare providers on the upcoming
educational conference. Dr. Andrew Lozen would assist in sending out the emails to the
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healthcare providers. The email includes a brochure that includes brief information about the
education intervention. The brochure would include the qualifying participants, which includes
nurse practitioners, physician assistants, medical residents, medical fellows, and attending
physicians that specialize in internal medicine or neurology. The recruitment brochure informs
the participants would be asked to take a pre-test and post-test. It also informs participants that
the entire presentation will not last longer than an hour. The contact information of the DNP
student, principal investigator and coinvestigators would also be provided (Moran et al, 2020).
Protection of Human Subjects/Data management
The Qualtrics system will collect the data after each education intervention. There will
not be any names or identifiers included to protect privacy and comply with the Health Insurance
Portability and Accountability Act (HIPPA). Also, an application will be completed and
submitted by Florida International University Review Boards to comply with the protection of
human subjects involved in the study and research ethics. The standards and interventions will be
encrypted and documented (Moran et al, 2020).
Data Collection, Management and Analysis Plan
The Qualtrics system included the pre-test and post-test data. Statistics and scores were
examined and compared. Practice habit questions and knowledge questions were analyzed
differently. Descriptive and comparative graphs will also be used. Based on the results,
conclusion will then be drawn to comprehend the effectiveness of the educational intervention
(Moran et al., 2020).
Results
This quality improvement project consisted of 13 participants; however, only 12 of them
completed the pre-test and post-test questionnaires. The demographic data of the participants
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who completed the survey can be found in Table 1. Nurse practitioners (n=6, 46.2%) was the
most common profession that were involved in the survey. Majority of the participants had three
or more years of experience in Internal Medicine. The response rate to the post-test was 92%.
There is an unclear reason for failure to complete the program by the one participant; however,
this participant may have not understood that a post-test was necessary to assess the effectiveness
of the educational intervention.
Table 1
Participant demographics
Physicians

Nurse Practitioner

Physician Assistants

# of Professionals

4

6

3

% of Professionals

30.8%

46.2%

23%

0-1 years

1-3 years

3 or more years

Years of Exp.

1

2

10

Experience %

7.7%

15.4%

76.9%

Overall, there was an improvement in the average scores between the pre-test and posttest surveys as seen in Table 2. In total, the overall scores increased by 5% after the educational
intervention. There was a 23% increase on the question regarding STK-5. Regarding the
definition of antiplatelet medications, an 8% increase was found after the educational
intervention. Post-test average score for the deadline for antiplatelet therapy initiation increased
by 12% when compared to the pre-test results. Regarding understanding stroke chameleons,
there was a 2% decrease in the post-test results. When discussing the appropriate aspirin dosage
for suspected stroke patients, there was a 23% increase in the post test results. The question
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regarding the appropriate unit for stable stroke patient resulted in a 2% decrease from the posttest. There was no change in the question regarding administering antiplatelets for patients who
failed the dysphagia screening. The last three questions were based on practicing habits. There
was a 3% decrease in the tendency to order brain images for patient suspected of stroke.
However, an 8% increase in the post-test was found in the question about prescribing an
antiplatelet therapy for stroke patients upon discharge. Lastly, there was a 1% increase in patient
education regarding follow up visits, medication prescribed at discharge, and warning signs of
stroke.
Table 2
Pre-test and post-test analysis
Questions

Pre-test average

Post-test average

Change

STK-5

69%

92%

+23%

Antiplatelet

8%

16%

+8%

Time of antiplatelet

38%

50%

+12%

Stroke Chameleon

77%

75%

-2%

Aspirin Dosage

69%

92%

+23%

Unit for stable stroke

85%

83%

-2%

Dysphagia screen

100%

100%

0

Ordering imaging

100%

97%

-3%

Discharge

92%

100%

+8%

Patient education

92%

93%

+1%

initiation

patients
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Total score

87%

93%

+5%

Pre-test analysis
Characterization.
Respondents were asked to complete a questionnaire. The pretest began with two
demographic questions, then seven knowledge-based questions, followed by three practice habit
questions. Overall, there was a 5% increase in the post-test questionnaire that followed the
educational intervention. The average score in percentage for the pre-test was 87% compared to
93% in the post-test questionnaire.
STK-5
The Joint Commission National Quality Measures describes STK-5 as antiplatelet
therapy by the end of hospital day two. This core measure is monitored throughout hospitals. It is
important for healthcare providers to be aware of this core measures as it relates to hospital
reimbursement for stroke patients. In the pre-test, 69% of healthcare providers answered this
question correctly. About 31% believed STK-5 was related to antiplatelet therapy, such as TPN.
None of the participants identified STK-5 as venous thromboembolism prophylaxis and the need
to assess stroke patients for rehabilitation.
Antiplatelet
Antiplatelet medications can be used interchangeably with antiplatelet medication. These
medications work by preventing platelet aggregation, which was response C. Majority of the
participants answered this incorrectly. About 77% of respondents (n=10) chose D, which stated
A and C. Response A stated that an antiplatelet is a drug that prevents the coagulation of blood
by reducing fibrin formation. The correct response is Response C, not Response D. Response D
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included Response A and Response C. Only one person (7.7%) answered the question correctly
and chose Response C. About 15% of participants (n=2) chose Response A. No respondents
chose Response B, which stated a drug that breaks down blood clots in blood vessels.
Time of Antiplatelet Initiation
The latest time to initiate antiplatelet therapy is by the end of hospital day two. For
example, if a patient was admitted to the hospital for rule out stroke at 11 PM on October 2,
2020, antiplatelet therapy should be initiated by 12 AM October 4th for eligible patients.
Therefore, the correct answer is option A. About 38% of healthcare providers (n=5) answered
this correctly. Five participants also chose option B, which stated by 12 AM October 3. Three
participants chose option C, which stated by 12 AM October 2. There were no participants that
chose option D, by 12 AM October 5th.
Stroke Chameleon
Question Four was a true or false question that defined stroke chameleon. Stroke
chameleons are known as patients that presented to the hospital with altered mental status,
syncope, and other non-localizing complaints that eventually are diagnosed with a stroke. 10
respondents (76.92%) chose true, which is the correct answer. Three of them chose false.
Aspirin dosage
The appropriate dosage for aspirin in the treatment of patients with suspected ischemic
stroke ranges from 81 mg to 325 mg. Nine participants (69.23%) answered correctly by choosing
Response B, which stated 81 mg to 325 mg. Four healthcare providers chose Response D, which
stated 162 mg to 243 mg. None of them chose Response A (81 mg to 330 mg) nor Response C
(126 mg to 400 mg).
Unit for stable stroke patients
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Stable stroke patients should be admitted to the step-down unit. About 85% of the
participants (n=11) answered this question correctly by choosing Answer C, which stated stepdown unit. One healthcare provider chose the telemetry unit (Answer B) and another chose the
intensive care unit (Answer D). There was no participant that chose the medical-surgical unit
(Answer A).
Dysphagia screen
The seventh question represented another true and false question. For a patient who failed
their dysphagia screening, antiplatelets can be administered rectally; therefore, the answer to this
question is true. All 13 responders chose true. There were not any respondents that answered this
question incorrectly by choosing false.
Ordering imaging
Question Eight aimed to assess the practice habits of these healthcare providers. The
purpose of this question was to understand how often healthcare providers were ordering brain
images, such as CT scan and MRI of the brain, for a patient suspected of stroke. All healthcare
providers chose response three, which stated always. Those who chose this earned three points.
Individuals who would have chosen response two, which stated it sometimes, would have scored
only two points. Lastly, those who would have chosen response one, which stated never, would
have not earned any points.
Discharge
The ninth question also intended to analyze the practice habits of healthcare providers in
regard to prescribing anti-thrombotic therapy for ischemic stroke patients upon discharge.
Majority of participants answered Response D (Greater than 75% of the time), which provided
the highest score of four. One participant chose Response C (50 to 75% of the time), which
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scored three points. Another one chose Response A (Less than 25% of the time), which earned
one point. No one chose Response B (25-50% of the time), which could’ve scored two points.
Patient education
The goal of Question Ten was to see how often healthcare providers provided stroke
patients with education with the need to follow up after discharge, medication as prescribed at
discharge, risk factors for stroke and warning signs of stroke. About 85% of healthcare providers
(n=11) chose Response Five, which stated always. One healthcare provider chose Response
Four, which stated most of the time. Another healthcare provider chose Response One, which
stated never. No one chose Response Two (sometimes) nor Response Three (about half the
time).
Post-test analysis
Characterization.
The participants were also asked to complete a post-test questionnaire following the
educational intervention. The post-test included the same seven knowledge-based question and
three practice habit questions as the pre-test. Overall, a 5% increase was found in the post-test.
The average score in percentage for the post-test was 93% compared to 87% in the pre-test
questionnaire.
STK-5
In the post-test, 91% of healthcare providers (n=11) answered this question correctly by
identifying STK-5 as antiplatelet therapy by the end of hospital day two. This was a significant
increase from 69% that answered the question correctly. One healthcare provider believed STK5 was related to antiplatelet therapy, such as TPN, compared to the 31% in the pretest. None of
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the healthcare providers identified STK-5 as venous thromboembolism prophylaxis and the need
to assess stroke patients for rehabilitation.
Antiplatelet
In the post-test survey, two participants (16.67%) answered the question correctly and
identified antiplatelet medications as medications that work by preventing platelet aggregation,
which was Response C. This was an increase compared to only one participant that answered
correctly in the pre-test. 75% of the participants still answered this incorrectly and chose
Response D, which stated A and C. On a positive note, this percentage decreased from 77% to
75%. One participant chose Response B, which stated drug that breaks down blood clot in blood
vessel. No participant chose Response A, which stated that an antiplatelet is a drug that prevents
the coagulation of blood by reducing fibrin formation.
Time of Antiplatelet Initiation
The correct answer is Option A, which stated by 12 AM October 4th. There was a 12%
increase in the post-test compared to the pre-test. Therefore, one more person answered
correctly. Four participants also chose Option B, which stated by 12 AM October 3. Three
participants chose Option C, which stated by 12 AM October 2. There were no participants that
chose Option D, by 12 AM October 5th.
Stroke Chameleon
Question Four was a true or false question that defined stroke chameleon as patients that
presented to the hospital with altered mental status, syncope, and other non-localizing complaints
that eventually are diagnosed with a stroke. Less respondents (n=9, 75%) answered this correctly
in the post-test than the pre-test, which had 10 correct answers (76.92%). Three respondents
chose false.
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Aspirin dosage
In the post-test questionnaire, more participants answered this question correctly. About
92% of the participants answered right compared to the 69% (n=9) in the pre-test. One healthcare
provider chose Option C, which stated 126 mg to 400 mg. None of them chose Response A (81
mg to 330 mg) nor Response D (162 mg to 243 mg).
Unit for stable stroke patients
As previously discussed in the pre-test analysis, stable stroke patient should be admitted
to the step-down unit. Less participants (n=10, 83.33%) answered this correctly in comparison to
the pre-test, which 85% of the participants (n=11) answered this question correctly. Two
participants chose Option B, telemetry unit. There was no participant that chose the medical
surgical unit (Option A) nor intensive care unit (Option D).
Dysphagia screen
Just as in the pre-test, all respondents (n=12) answered correctly by picking true. True
meant that patients who failed their dysphagia screening may still receive antiplatelet
medication, which could be administered rectally. There were not any respondents that answered
this question incorrectly.
Ordering imaging
The eighth question aimed to assess the practice habits of these healthcare providers and
understand how often healthcare providers were ordering brain images, such as CT scan and
MRI of the brain, for a patient suspected of stroke. There was a slightly less favorable response
to this question. 11/12 healthcare providers chose Response Three, which stated always. Those
who chose this received three points. In the pre-test, all the healthcare providers chose Response
Three or always. One individual chose Response Two, which stated sometimes. This person
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received two points. Lastly, those who would have chosen response one, which stated never,
would have scored one point.
Discharge
Question Nine also intended to analyze the practice habits of healthcare providers
regarding prescribing antiplatelet therapy for ischemic stroke patients upon discharge. There was
a better response in the post-test compared to the pre-test. All participants picked Response D
(Greater than 75% of the time), which provided the highest score of four. No other participant
chose Response C (50 to 75% of the time), Response A (Less than 25% of the time), nor
Response B (25-50% of the time).
Patient education
As stated in the pre-test analysis, the aim of question 10 was to see how often healthcare
providers provided stroke patients with education with the need to follow up after discharge,
medication as prescribed at discharge, risk factors for stroke and warning signs of stroke. There
was a slightly worse response in the post-test compared to the pre-test. About 83% of healthcare
providers (n=10) chose Response Five, which stated always in comparison to 85% in the pre-test.
One healthcare provider chose Response Four, which stated most of the time. Another healthcare
provider chose Response Two, which stated sometimes. None chose Response One (never) nor
Response Three (about half the time).
Discussion
Overall, the average scores improved after participants completed the educational
intervention. There were improvements found in the STK-5 core measure, understanding of the
significance of antiplatelet medications, the proper timeline to initiating antiplatelet therapy and
the appropriate dose for aspirin in treating patients with stroke. The educational intervention also
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improved the practice habits of healthcare providers by encouraging them to discharge eligible
patients on antiplatelet medications and educating them on stroke and stroke management. Out of
the 10 categories, only three sections showed negative impacts. The biggest difference was a -3%
impact on the practice habits of ordering images for stroke patients. Understanding stroke
chameleons and where to send stable stroke patient also showed a negative influence of -2%.
Regarding administering antiplatelet medications to patients who failed their dysphagia
screening, there was no improvement because all participants answered the question correctly.
Considering all this, an educational intervention proved that it could improve the
knowledge of healthcare providers and improve their practice habits in prescribing antiplatelet
medications to patients with stroke symptoms within 48 hours upon arrival to the hospital. This
will lead to better patient care when treating patients with stroke.
Limitations
Like many quality improvement projects, there were a few limitations that concerned this
DNP project while developing an educational intervention. Due to the impact of the COVID-19
pandemic, in-person interactions were restricted. This could have affected the effectiveness of
the educational intervention. Participants would have felt more encouraged to ask questions to a
particular subject they may not have understood well. Since the pre-test and post-test survey
were given electronically, participants were not supervised and could have used testing aids to
help them answer certain questions. However, the findings of this study should be examined
considering these limitations. Through persistence, this quality improvement project was able to
work around these limitations and provide enough evidence to conclude this study.
Implication for Advanced Nursing Practice
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Antiplatelet therapy plays an integral role in ischemic stroke prevention and management.
Healthcare providers should be familiar with the latest guidelines for treatment of ischemic
stroke to prevent negative consequences. These negative consequences include the physical,
economic, and mental effects that were discussed earlier (Johnston et al., 2018). Not only should
healthcare providers be aware of the significance of antiplatelet therapy, but they should also be
knowledgeable enough to be able to teach patients on the need for antiplatelet therapy and
importance of adhering to the therapy (Faiz et al., 2019). Healthcare providers should also
educate patient on the complication of antiplatelet therapy, which includes bleeding. Also, they
must also be aware of barriers for medication adherence, such as patients with a history of
dementia and medication noncompliance (Faiz et al. 2019).
This quality improvement project impacts the nursing practice in the school and
outpatient settings as well. Nursing students will be encouraged to check for antiplatelet therapy
in patients admitted for ischemic stroke. They would be more knowledgeable to educate their
preceptor and motivate them to call healthcare providers to start their patients on antiplatelet
therapy if there are no contraindications. From an outpatient perspective, this quality
improvement project could encourage primary care providers to encourage their patients to stay
compliant with antiplatelet therapy to prevent the recurrency of stroke.
Conclusion
It is practical to improve the knowledge of healthcare providers regarding early initiation
of antiplatelet therapy for patients with stroke symptoms through an educational intervention.
Improving this knowledge should result in a better outcome of stroke management. Over time,
stroke patients will be able to manage their illness better with antiplatelets medications, which
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would limit the negative impacts that stroke may bring to their physical, mental, and financial
situations.
Dissemination
The dissemination plan is very essential to any scholarly work. It increases the awareness
of the research to enhance the goals of the quality improvement project. Evident research
findings encourage stakeholders to engage in more evidence-based practices, which would
improve the health outcomes of patients. The stakeholders for this quality improvement project
were executive members, physicians, nurse practitioners, physician assistants and registered
nurses.
This quality improvement project has several dissemination plans. Initially, the quality
improvement project would be presented at the acute care hospital that was reviewed in the
study. This would aim to improve healthcare providers’ adherence to prescribe antiplatelets for
eligible patient with stroke symptoms within the first 48 hours upon arrival. Also, this quality
improvement project would be presented at a Florida Nurses’ Association conference. This
would encourage other clinicians to conduct educational interventions to improve the knowledge
of healthcare providers. Thirdly, this quality improvement project paper would be submitted to
the American Academy of Neurology journal. This would serve to educate others on improving
antiplatelet therapy utilization and promote educational interventions to improve the knowledge
of healthcare providers.
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Appendix A: Recruitment Materials

How much do you know about treating
patients with stroke symptoms?
underrepresented in aging research?

How to qualify: Nurse practitioners, Physician assistants, Medical
Residents, Medical Fellows, and Physicians
What will you do: Take a pre-test, view educational intervention PowerPoint,
and take a post educational intervention test
How much time: 1 hour
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“Let’s improve stroke care”
Volunteers are needed to improve stroke care throughout the
hospital.

For additional Information please contact:
James Celestin, MSN, FNP-C
Principal Investigator:
Florida International University
Nicole Wertheim College of
Nursing
● Phone: (786) 873-9735
● Email:
jacelestin08@yahoo.com

Mechell Duran, DNP, APRN,
FNP-BC, BC-ADM, CDCES,
Clinical Assistant Professor
Florida International
University Nicole Wertheim
College of Nursing
Email: meadavi@fiu.edu

Dr. Andrew Lozen, M.D.
Stroke Program Director
Wayne State University
School of Medicine
● Email:
andrewlozen@yahoo.com

Florida Aging Registry is sponsored by the National Institute on Aging #

FIU IRB #
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Appendix B: Informational Letter

You are being asked to participate in a quality improvement project at Aventura Hospital and
Medical Center. The principal investigator of this quality improvement project is Dr. Mechell
Duran, a faculty member at Florida International University. The co-investigators of this project
are James Celestin, a doctoral candidate at FIU, and Dr. Lozen, medical director of the stroke
committee at Aventura Hospital and Medical Center. This project will include 25 healthcare
professionals. Presentation may last an hour. You’ll be given a pre-test, undergo an educational
intervention, and take a post-test to evaluate the effectiveness of the educational intervention
regarding early initiation of antiplatelet therapy for stroke patients. The quality improvement
project aims to improve the knowledge of healthcare providers on stroke treatment and improve
patient outcomes in the acute care setting.

Completion of this quality improvement project is completely voluntary.

If you agree to partake in this study and complete the pre-and post-questionnaire, all your
responses will be strictly confidential. Only Dr. Duran, Dr. Lozen, and James Celestin will see
the individual surveys. Information collected from this study will only be shared in research
reports. No information will be given that could identify your responses. There is no foreseeable
risk but to improve your knowledge, efficiency and delivering care for stroke patients.

If you volunteer to participate in this quality improvement project, please complete the preintervention questionnaire regarding your knowledge and habits for caring for patients with
ischemic stroke. After completing the pre-intervention questionnaire, you will participate in a 30minute presentation on stroke and its treatments. After the presentation, you’ll be given a post
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intervention questionnaire. Please answer these questions to the best of your knowledge even if
you’re unsure of the answer. If you agree to participate in this quality improvement project, you
are free to withdraw at any time without any negative effect on your relationship with Aventura
Hospital and Medical Center, FIU, and all the investigators involved in the study.

I appreciate your participation, and I am available to answer any questions while taking part in
this study. If you have any questions later, you may contact me, James Celestin, at 786-873-9735
and Dr. Mechell Duran at 786-547-9933. If you wish to discuss about your rights of being a
research subject in the study, you may contact the FIU Office of Research Integrity by phone at
305-348-2494 or by email at ori@fiu.edu. You will be provided with a copy of this for your
records.
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Appendix C: Organizational Support Letter
Dr. Andrew Lozen
Medical Director of Neurosurgical Specialist of South Florida
21097 NE 27th Ct, Suite 320
Aventura, FL 33180

February 2, 2021

Title: Healthcare provider’s behaviors in prescribing antiplatelet therapy for patients with stroke
symptoms within 48 hours upon arrival in hospital

Dear Florida International University IRB Review Committee,

I am encouraged to compose this letter in substantial support of James Celestin’s IRB application
for the quality improvement project “Healthcare provider’s behaviors in prescribing antiplatelet
therapy for patients with stroke symptoms within 48 hours upon arrival in hospital.” I concur that
Aventura Hospital and Medical Center will serve as the study site for this quality improvement
project. The quality improvement project will be led by Dr. Mechell Duran, DNP, APRN, FNPBC ADM, CDCES and James Celestin, MSN, APRN, FNP-C at Florida International University.

This letter authorizes the readiness of Aventura Hospital and Medical Center to depend on
another IRB for the evaluation of your activities. I recognize Florida International IRB will
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function as the single IRB for this quality improvement project, and we would be satisfied to
depend upon their evaluation.

Sincerely,

Dr. Andrew Lozen
Medical Director of Neurosurgical Specialist of South Florida

50
Appendix D: Pre-Test
1. What is your profession?
A. Nurse Practitioner
B. Attending physician
C. Physician assistant
D. Medical resident
E. Medical fellow
2. How long have you been in the profession?
A. 0-1 years
B. 1-3 years
C. 3 or more years
3. Which choice best describes STK-5?
A. Venous Thromboembolism (VTE) Prophylaxis
B. Thrombolytic Therapy
C. Assessed for Rehabilitation
D. Antiplatelet Therapy By End of Hospital Day 2
4. What is an antiplatelet medication?
A. A drug that prevents the coagulation of blood by reducing fibrin formation
B. A drug that breaks down blood clots in blood vessels
C. A drug that prevents blood clots by preventing platelet aggregation
D. Both A and C
5. If a patient was admitted to the hospital for rule out stroke at 11 PM on October 2, 2020,
when is the latest time it is appropriate to initiate antiplatelet therapy?
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A. By 12 AM October 4th
B. By 12 AM October 3rd
C. By 12 AM October 5th
D. By 12 AM October 2nd
6. Patients presenting with altered mental status, syncope, and other non-localizing
complaints may be subsequently diagnosed with minor ischemic or hemorrhagic strokes
can be termed as stroke chameleon. T or F
7. What is the appropriate those for aspirin?
A. 81mg to 330 mg
B. 81mg to 325 mg
C. 126 mg to 400 mg
D. 162 mg to 243 mg
8. Where do you admit stable stroke patient?
A. Medical surgical unit
B. Telemetry unit
C. Step down unit
D. Intensive care unit
9. If a patient fails their dysphagia screening, do you still administer anti-platelets? T or F
10. How often do you order brain imaging such as CT scan, MRI, for patients suspected of
stroke?
A. Never
B. Sometimes
C. Always
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11. How often do you prescribe anti-thrombotic therapy for ischemic stroke patients at
discharge?
A. less than 25% of the time
B. 25 to 50% of the time
C. 50 to 75% of the time
D. Greater than 75% of the time
12. How often do you provide stroke patient with education on their need to follow up after
discharge, medication as prescribed at discharge, risk factors for a stroke and warning
signs of stroke?
A. Less than 25% of the time
B. 25 to 50% of the time
C. 50 to 75% of the time
D. Greater than 75% of the time
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Appendix E: Post-Test

1. What is an antiplatelet medication?
E. A drug that prevents the coagulation of blood by reducing fibrin formation
F. A drug that breaks down blood clots in blood vessels
G. A drug that prevents blood clots by preventing platelet aggregation
H. Both A and C
2. If a patient was admitted to the hospital for rule out stroke at 11 PM on October 2, 2020,
when is the latest time it is appropriate to initiate antiplatelet therapy?
E. By 12 AM October 4th
F. By 12 AM October 3rd
G. By 12 AM October 5th
H. By 12 AM October 2nd
3. Patients presenting with altered mental status, syncope, and other non-localizing
complaints may be subsequently diagnosed with minor ischemic or hemorrhagic strokes
can be termed as stroke chameleon. T or F
4. What is the appropriate those for aspirin?
E. 81mg to 330 mg
F. 81mg to 325 mg
G. 126 mg to 400 mg
H. 162 mg to 243 mg
5. Where do you admit stable stroke patient?
E. Medical surgical unit
F. Telemetry unit
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G. Step down unit
H. Intensive care unit
6. If a patient fails their dysphagia screening, do you still administer anti-platelets? T or F
7. How likely are you to order brain imaging such as CT scan, MRI, for patients suspected
of stroke?
D. Never
E. Sometimes
F. Always
8. How likely are you to prescribe anti-thrombotic therapy for ischemic stroke patients at
discharge?
E. less than 25% of the time
F. 25 to 50% of the time
G. 50 to 75% of the time
H. Greater than 75% of the time
9. How likely are you to provide stroke patient with education on their need to follow up
after discharge, medication as prescribed at discharge, risk factors for a stroke and
warning signs of stroke?
E. Less than 25% of the time
F. 25 to 50% of the time
G. 50 to 75% of the time
H. Greater than 75% of the time
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Appendix F: IRB Approval Letter
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Appendix G: IRB Amendment Approval Letter
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Appendix H: Healthcare Provider Antiplatelet Education

Improving antiplatelet therapy
initiation for patients with an
ischemic stroke

• James Celestin
• Dr. Mechell Duran
• Dr. Andrew Lozen

Learning Objectives
• Understand the core measure, STK-5
• Explain how antithrombotic therapy works
• Know the latest recommended time a clinician can initiate antiplatelet therapy
• Distinguish stroke chameleons
• Learn the appropriate dose of aspirin for treating patients with ischemic stroke
• Understand where stroke patients should be admitted to
• Understand the different routes aspirin can be administered
• Assess habits of ordering CT brain for patients with suspected stroke
• Assess prescribing habits of initiating antiplatelet therapy
• Assess habits on stroke education for patients on antiplatelet therapy
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Stroke Introduction
• A cerebral vascular accident, also known as
stroke, occurs when there is an interruption of
blood flow to the brain (Sbampato dos Santos et
al., 2017).
• It is one of the world’s leading cause of mortality
and disability (Sbampato dos Santos et al., 2017).
• It is imperative to recognize the signs of stroke
and act appropriately to reduce the effects of the
disease.
• Antiplatelets have shown to limit the mortality
and recurrence rate of patients with ischemic
stroke.

Significance
• In 2010, the mortality and morbidity of stroke impacted
the United States by $73 billion.
• Due to the difficulty of a full recovery for cerebral
vascular accidents, stroke prevention is the top priority
in the approach to reduce the mortality and morbidity
of the disease.
• While someone experiences a stroke every 40 seconds,
an individual dies from stroke every 4 minutes.
• In Miami-Dade County, stroke is the third leading cause
of death in Miami-Dade County. This condition accounts
for 41.5 deaths per 100,000 population from 20152017.

Consequences of stroke
Physical

Mental

• Visual deficits
• One sided
weakness/numbness
• Difficulty walking
• Speech abnormalities

• Behavioral changes
• Memory loss
• Stress from lifestyle
changes
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Problem Statement
• One of the best treatment for stroke is by starting
timely antiplatelet therapy if patient is not a
candidate for TPA or mechanical thrombectomy
• In order for antithrombotic medications to be
effective, it is recommended that this medication is
given to patients within 48 hours upon arrival to
the hospital along as there are no
contraindications.
• However, many healthcare providers are not
adhering to prescribing antiplatelets within 48
hours upon arrival to the hospital.

Aspirin
• 81 mg to 325 mg
• Can also be given
suppository if pt unable
to swallow

Mechanism of action
• irreversibly inhibits
prostaglandin H
synthase
(cyclooxygenase-1) in
platelets and
megakaryocytes, and
thereby blocks the
formation of
thromboxane A2 (TXA2;
a potent
vasoconstrictor and
platelet aggregant).
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Stroke Core Measures
• STK-1 : Venous Thromboembolism (VTE) Prophylaxis by admission day 2. (Ischemic and
Hemorrhagic)
• STK-2 Discharged on Anti-thrombotic Therapy. (Ischemic)
• STK-3 Anticoagulation Therapy for Atrial Fibrillation/ Flutter. (Ischemic)
• Upon Discharge and while admitted unless contraindicated (Documentation must
reflect)
• STK-4 Thrombolytic Therapy (if applicable) within 60 minutes of patient arrival.
(Ischemic)
• STK-5 Anti-thrombotic Therapy by end of hospital day 2. (Ischemic)
• STK-6 Discharged on a Statin. (Ischemic) if LDL is 70 or greater
• STK-8 Stroke Education (Patient Specific Risk Factors Addressed).(Ischemic and
Hemorrhagic)
• STK-10 Assessed for Rehabilitation. (Ischemic and Hemorrhagic)

Stroke Chameleon
• Patients presenting with altered mental status,
syncope, and other non-localizing complaints may
be subsequently diagnosed with minor ischemic or
hemorrhagic strokes
• Check for risk factors (HTN, DM, smoking,
dyslipidemia, lack of exercise, obesity)

All patients who are
admitted with a
CVA/TIA or Rule out
CVA/TIA diagnosis
must be admitted
under the Stroke/TIA
Order-sets. This is a
One Stop Shop for
Stroke Core
Measures .

Remember STK-1 and
STK -5 go by the Arrival
Date NOT the Admit
Date.
EXAMPLE.
Patient arrived to the
hospital 7/8/2019
22:00, end of hospital
day 2 is 7/9/2019 @
23:59

All stable patients suspected
for stroke should be admitted
to stepdown.
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Documentation for
ASA Contraindication
must be placed in
CPOE. If an
alternative is
available please
ensure it is ordered
before hospital day
2.

Questions?
• Email: andrewlozen@yahoo.com

